HIGHLIGHTS
- who: Report and collaborators from the Internal Medicine, University of Connecticut, Farmington, USA Hematology and Oncology, Cleveland Clinic have published the research: Review began 05/22/2022 Review ended 06/10/2022 Published 06/13/2022 u00a9 Copyright, in the Journal: (JOURNAL) of June/13,/2022
- how: Indicated that the JAK2 inhibitor significantly increased the cytotoxic effect of erlotinib on erlotinibresistant NSCLC cells .
SUMMARY
Lung cancer accounts for roughly 58% of the total cancer deaths worldwide. Liquid biopsies, also known as circulating free DNA (cfDNA), are a new tool that can . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.